Deborah Weitzman

Insider Reports History

Location
Dublin, OH
Signature
/s/ James E. Barnett, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Sponsored

Holdings reported by Deborah Weitzman:

Company Role Class Num Shares Value Price $ Report Date Ownership
CARDINAL HEALTH INC CEO, PSS Segment Common Shares 52,877 $11,223,672 $212.26 01 Dec 2025 Direct

Insider Reports Filed by Deborah Weitzman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CAH CARDINAL HEALTH INC 01 Dec 2025 1 -$116,955 4 CEO, PSS Segment 02 Dec 2025, 16:11
CAH CARDINAL HEALTH INC 20 Aug 2025 1 -$3,216,375 4 CEO, PSS Segment 20 Aug 2025, 16:12
CAH CARDINAL HEALTH INC 15 Aug 2025 2 -$3,624,508 4 CEO, PSS Segment 19 Aug 2025, 19:20
CAH CARDINAL HEALTH INC 12 Aug 2025 1 $0 4 CEO, PSS Segment 12 Aug 2025, 16:19
CAH CARDINAL HEALTH INC 02 Dec 2024 1 -$77,256 4 CEO, PSS Segment 03 Dec 2024, 16:18
CAH CARDINAL HEALTH INC 15 Aug 2024 3 -$1,307,496 4 CEO, PSS Segment 19 Aug 2024, 20:15
CAH CARDINAL HEALTH INC 13 Aug 2024 1 $0 4 CEO, PSS Segment 14 Aug 2024, 16:29
CAH CARDINAL HEALTH INC 01 Dec 2023 1 -$68,317 4 CEO, Pharmaceutical Segment 05 Dec 2023, 16:42
CAH CARDINAL HEALTH INC 27 Nov 2023 7 -$1,847,055 4 CEO, Pharmaceutical Segment 29 Nov 2023, 09:14
CAH CARDINAL HEALTH INC 28 Aug 2023 3 -$123,367 4 CEO, Pharmaceutical Segment 29 Aug 2023, 16:21
CAH CARDINAL HEALTH INC 15 Aug 2023 2 -$1,019,728 4 CEO, Pharmaceutical Segment 17 Aug 2023, 19:51
CAH CARDINAL HEALTH INC 07 Aug 2023 1 $0 4 CEO, Pharmaceutical Segment 08 Aug 2023, 19:42
CAH CARDINAL HEALTH INC 01 Dec 2022 1 -$30,465 4 CEO, Pharmaceutical Segment 05 Dec 2022, 15:29
CAH CARDINAL HEALTH INC 19 Sep 2022 0 $0 3 CEO, Pharmaceutical Segment 29 Sep 2022, 08:31